Your browser doesn't support javascript.
loading
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
Horwich, A; Babjuk, M; Bellmunt, J; Bruins, H M; De Reijke, T M; De Santis, M; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, M J; Shariat, S F; Van Der Kwast, T; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, P C; Bochner, B H; Bolla, M; Boormans, J L; Bossi, A; Briganti, A; Brummelhuis, I; Burger, M; Castellano, D; Cathomas, R; Chiti, A; Choudhury, A; Compérat, E; Crabb, S; Culine, S; De Bari, B; DeBlok, W; De Visschere, P J L; Decaestecker, K; Dimitropoulos, K; Dominguez-Escrig, J L; Fanti, S; Fonteyne, V; Frydenberg, M; Futterer, J J; Gakis, G; Geavlete, B; Gontero, P; Grubmüller, B; Hafeez, S; Hansel, D E.
Afiliação
  • Horwich A; Emeritus Professor, The Institute of Cancer Research, London, UK; Emeritus Professor, The Institute of Cancer Research, London, UK. Electronic address: clinicalguidelines@esmo.org.
  • Babjuk M; Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Bellmunt J; IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; Harvard Medical School, Boston, USA.
  • Bruins HM; Department of Urology, Radboud University Medical Center, Nijmegen.
  • De Reijke TM; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • De Santis M; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Charité University Hospital, Berlin, Germany.
  • Gillessen S; Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St Gallen, St Gallen; University of Bern, Bern, Switzerland.
  • James N; University Hospitals Birmingham NHS Foundation Trust, Birmingham; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.
  • Maclennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
  • Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Powles T; The Royal Free NHS Trust, London; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Ribal MJ; Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Shariat SF; Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York; Department of Urology, University of Texas Southwestern Med
  • Van Der Kwast T; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique Hôpitaux de Paris, Paris; Paris Descartes University, Paris, France.
  • Agarwal N; Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, USA.
  • Arends T; Urology Department, Canisius-Wilhelmina Ziekenhuis Nijmegen, Nijmegen, The Netherlands.
  • Bamias A; 2nd Propaedeutic Dept of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
  • Birtle A; Division of Cancer Sciences, University of Manchester, Manchester; Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK.
  • Black PC; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Bochner BH; Department of Urology, Weill Cornell Medical College, New York; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Bolla M; Emeritus Professor of Radiation Oncology, Grenoble - Alpes University, Grenoble, France.
  • Boormans JL; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Bossi A; Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France.
  • Briganti A; Department of Urology, Urological Research Institute, Milan; Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
  • Brummelhuis I; Department of Urology, Radboud University Medical Center, Nijmegen.
  • Burger M; Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Castellano D; Medical Oncology Department, 12 de Octubre University Hospital (CIBERONC), Madrid, Spain.
  • Cathomas R; Department Innere Medizin, Abteilung Onkologie und Hämatologie, Kantonsspital Graubünden, Chur, Switzerland.
  • Chiti A; Department of Biomedical Sciences, Humanitas University, Milan; Humanitas Research Hospital, Milan, Italy.
  • Choudhury A; Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK.
  • Compérat E; Department of Pathology, Tenon Hospital, HUEP, Paris; Sorbonne University, Paris, France.
  • Crabb S; Cancer Sciences Unit, University of Southampton, Southampton, UK.
  • Culine S; Department of Cancer Medicine, Hôpital Saint Louis, Paris.
  • De Bari B; Radiation Oncology Department, Centre Hospitalier Régional Universitaire "Jean Minjoz" of Besançon, INSERM UMR 1098, Besançon, France; Radiation Oncology Department, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Switzerland.
  • DeBlok W; Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • De Visschere PJL; Department of Radiology and Nuclear Medicine, Division of Genitourinary Radiology and Mammography, Ghent University Hospital, Ghent.
  • Decaestecker K; Department of Urology, Ghent University Hospital, Ghent, Belgium.
  • Dimitropoulos K; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Dominguez-Escrig JL; Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Fanti S; Department of Nuclear Medicine, Policlinico S Orsola, University of Bologna, Bologna, Italy.
  • Fonteyne V; Department of Radiotherapy Oncology, Ghent University Hospital, Ghent, Belgium.
  • Frydenberg M; Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
  • Futterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gakis G; Department of Urology and Paediatric Urology, University Hospital of Würzburg, Julius-Maximillians University, Würzburg, Germany.
  • Geavlete B; Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania.
  • Gontero P; Division of Urology, Molinette Hospital, University of Studies of Torino, Torino, Italy.
  • Grubmüller B; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Hafeez S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
  • Hansel DE; Department of Urology, University of California, San Diego Pathology, La Jolla, USA.
Ann Oncol ; 30(11): 1697-1727, 2019 11 01.
Article em En | MEDLINE | ID: mdl-31740927
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urologia / Neoplasias da Bexiga Urinária / Guias de Prática Clínica como Assunto / Consenso / Oncologia Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urologia / Neoplasias da Bexiga Urinária / Guias de Prática Clínica como Assunto / Consenso / Oncologia Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article